Healthcare provider profile · identity verified

Sherry K Schott, MD

Internal Medicine · WINCHESTER, VA · NPI 1124083191

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	955	259
Levothyroxine Sodium	Levothyroxine Sodium	436	105
Amlodipine Besylate	Amlodipine Besylate	423	114
Rosuvastatin Calcium	Rosuvastatin Calcium	412	120
Lisinopril	Lisinopril	287	79
Losartan Potassium	Losartan Potassium	232	62
Olmesartan Medoxomil	Olmesartan Medoxomil	220	62
Metformin Hcl	Metformin Hcl	216	64
Metoprolol Succinate	Metoprolol Succinate	213	57
Omeprazole	Omeprazole	174	53
Alendronate Sodium	Alendronate Sodium	167	44
Metformin Hcl Er	Metformin Hcl	155	46
Potassium Chloride	Potassium Chloride	146	47
Escitalopram Oxalate	Escitalopram Oxalate	131	41
Pantoprazole Sodium	Pantoprazole Sodium	125	34
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	114	31
Trazodone Hcl	Trazodone Hcl	113	29
Ezetimibe	Ezetimibe	111	38
Jardiance	Empagliflozin	111	23
Hydrochlorothiazide	Hydrochlorothiazide	110	32
Simvastatin	Simvastatin	108	32
Furosemide	Furosemide	98	35
Fluoxetine Hcl	Fluoxetine Hcl	96	27
Gabapentin	Gabapentin	89	26
Fluticasone Propionate	Fluticasone Propionate	87	28
Bupropion Xl	Bupropion Hcl	84	20
Telmisartan	Telmisartan	84	24
Spironolactone	Spironolactone	83	26
Eliquis	Apixaban	82	21
Synthroid	Levothyroxine Sodium	81	24
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	80	26
Hydralazine Hcl	Hydralazine Hcl	79	21
Trulicity	Dulaglutide	79	12
Mounjaro	Tirzepatide	77	12
Montelukast Sodium	Montelukast Sodium	76	23
Metoprolol Tartrate	Metoprolol Tartrate	74	21
Duloxetine Hcl	Duloxetine Hcl	72	21
Albuterol Sulfate Hfa	Albuterol Sulfate	71	27
Sertraline Hcl	Sertraline Hcl	70	17
Glimepiride	Glimepiride	67	19
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	67	21
Ozempic	Semaglutide	67	16
Zolpidem Tartrate	Zolpidem Tartrate	67	17
Pravastatin Sodium	Pravastatin Sodium	64	20
Valsartan	Valsartan	64	18
Irbesartan	Irbesartan	63	13
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	60	17
Alprazolam	Alprazolam	56	17
Tamsulosin Hcl	Tamsulosin Hcl	53	16
Atenolol	Atenolol	49	13
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	49	49
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	48	45
Doxazosin Mesylate	Doxazosin Mesylate	45	11
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	45	15
Allopurinol	Allopurinol	44	14
Famotidine	Famotidine	43	11
Donepezil Hcl	Donepezil Hcl	38	suppressed
Xarelto	Rivaroxaban	38	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	34	suppressed
Carvedilol	Carvedilol	31	suppressed
Olmesartan-Amlodipine-Hctz	Olmesartan/Amlodipin/Hcthiazid	31	suppressed
Pregabalin	Pregabalin	31	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	30	21
Cephalexin	Cephalexin	29	29
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	29	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	29	suppressed
Valacyclovir	Valacyclovir Hcl	28	13
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	26	suppressed
Citalopram Hbr	Citalopram Hydrobromide	25	suppressed
Lorazepam	Lorazepam	25	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	24	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	24	suppressed
Meclizine Hcl	Meclizine Hcl	24	14
Paroxetine Hcl	Paroxetine Hcl	24	suppressed
Prednisone	Prednisone	24	23
Clopidogrel	Clopidogrel Bisulfate	23	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	23	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	21	suppressed
Azithromycin	Azithromycin	21	21
Fenofibrate	Fenofibrate	21	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	21	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	20	20
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	19	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	18	suppressed
Mirtazapine	Mirtazapine	18	suppressed
Novolog Flexpen	Insulin Aspart	18	suppressed
Tramadol Hcl	Tramadol Hcl	18	suppressed
Clonidine Hcl	Clonidine Hcl	17	suppressed
Benazepril Hcl	Benazepril Hcl	16	suppressed
Humalog Kwikpen U-100	Insulin Lispro	16	suppressed
Nitroglycerin	Nitroglycerin	16	suppressed
Ipratropium Bromide	Ipratropium Bromide	15	suppressed
Ondansetron Odt	Ondansetron	15	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	15	suppressed
Folic Acid	Folic Acid	14	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	14	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	13	suppressed
Buspirone Hcl	Buspirone Hcl	13	suppressed
Klayesta	Nystatin	13	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	13	suppressed
Telmisartan-Hydrochlorothiazid	Telmisartan/Hydrochlorothiazid	13	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	12	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	12	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	12	12
Jantoven	Warfarin Sodium	12	suppressed
Klor-Con M20	Potassium Chloride	12	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	12	suppressed
Ondansetron Hcl	Ondansetron Hcl	12	suppressed
Symbicort	Budesonide/Formoterol Fumarate	12	suppressed
Warfarin Sodium	Warfarin Sodium	12	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	11	suppressed
Klor-Con M10	Potassium Chloride	11	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Levemir Flexpen	Insulin Detemir	11	suppressed
Tiadylt Er	Diltiazem Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error